LIVE

/Arceus/Sceptile

Variants

STANDARD · Conviction 5/10

Sceptile

Arceus · #30 · Rare

Live NM ask

€5.14

↑ 14.7% 30D

PSA 9

€0.00

USD source

PSA 10

€0.00

USD source

Composite

5.3

Confidence 5/10

5.3

Not yet verified

View listing →View price reference →

Buy range€3.16 – €4.13Above market

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.3

SCORE / 10

Liquidity

8.7

Scarcity

10.0

Era potential

4.4

Friction

6.4

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 3.23%Total population

PSA 10

PSA 9

PSA 8

Total graded

Gem rate 3.23%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Sceptile from the Arceus set (#30) currently trades at €5.14 in the raw market. Over the past 30 days the card has appreciated +14.7%. By market value it ranks #38 of 111 in Arceus — the 65th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a mid-tier ranking in Arceus alongside rising 30-day momentum frames where Sceptile sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.